Manuel Solé

Featured publications

• Liver metastases from gastric adenocarcinoma mimicking multinodular hepatocellular carcinoma.

  Authors:

  Díaz-González Á; Monclús E; Darnell A; Solé M; Bruix J ;

  Reference: HEPATOLOGY.

• Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: relevance of non-characterized nodules

  Authors:

  Marino, Zoe; Darne, Anna; Lens, Sabela; Sapena, Victor; Diaz, Alba;

  (...)

  Ayuso, Carmen; Rios, Jose; Forns, Xavier; Bruix, Jordi; Reig, Maria.

  See complete list of authors

  Reference: Journal Of Hepatology 2019.

• Molecular Classification and Potential Therapeutic Targets in Extrahepatic Cholangiocarcinoma

  Authors:

  Montal, Robert; Leow, Wei-Qiang; Montironi, Carla; Bassaganyas, Laia; Moeini, Agrin;

  (...)

  Thung, Swan N.; Roayaie, Sasan; Villanueva, Augusto; Schwartz, Myron E.; Llovet, Josep M.;.

  See complete list of authors

  Reference: HEPATOLOGY 2018.

• Safety of Hepatitis C Virus (HCV) treated donors for kidney transplantation (KT) excluding occult HCV infection through kidney biopsies.

  Authors:

  Gelpi R; Rodríguez-Villar C; Paredes D; Roque R; Ruiz A;

  (...)

  Martinez M; Navarro M; Lens S; Oppenheimer F; Diekmann F .

  See complete list of authors

  Reference: TRANSPLANT INTERNATIONAL 2018; 31(8):938-939.

• Treatment of Active Chronic Antibody-Mediated Rejection with Rituximab, IVIG and Plasma Exchange.

  Authors:

  Pineiro, G.; Rovira, J.; De Sousa-Amorim, E.; Villarreal, J.; Sole, M.;

  (...)

  Lozano, M.; Palou, E.; Oppenheimer, F.; Campistol, J.; Diekmann, F.;.

  See complete list of authors

  Reference: AMERICAN JOURNAL OF TRANSPLANTATION 2018.

• Rituximab, plasma exchange and immunoglobulins: An ineffective treatment for chronic active antibody-mediated rejection

  Authors:

  Piñeiro GJ; De Sousa-Amorim E; Solé M; Ríos J; Lozano M;

  (...)

  Palou E; Campistol JM; Oppenheimer F; Rovira J; Diekmann F.

  See complete list of authors

  Reference: BMC NEPHROLOGY 2018; 19(1):261-261.

• Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma

  Authors:

  Tovar, Victoria; Cornella, Helena; Moeini, Agrin; Vidal, Samuel; Hoshida, Yujin;

  (...)

  Desbois-Mouthon, Christele; Sole, Manel; Domingo-Domenech, Josep; Villanueva, Augusto; Llovet, Josep M.;.

  See complete list of authors

  Reference: GUT 2017.

• IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models

  Authors:

  Martinez-Quetglas I.; Pinyol R.; Dauch D.; Torrecilla S.; Tovar V.;

  (...)

  Villanueva A.; Thung S.; Esteller M.; Zender L.; Llovet J..

  See complete list of authors

  Reference: GASTROENTEROLOGY 2016.

• Borderline rejection in ABO-Incompatible Kidney Transplantation

  Authors:

  Sánchez-Escuredo A; Oppenheimer F; Solé M; Revuelta I; Cid J;

  (...)

  Paredes D; Musquera M; Ercilla G; Campistol JM; Diekmann F .

  See complete list of authors

  Reference: CLINICAL TRANSPLANTATION 2016; 30(8):872-879.

• Evaluation of a Mixing versus a Cycling Strategy of Antibiotic Use in Critically-Ill Medical Patients: Impact on Acquisition of Resistant Microorganisms and Clinical Outcomes

  Authors:

  Cobos-Trigueros N; Solé M; Castro P; Torres JL; Rinaudo M;

  (...)

  Soriano A; Nicolás JM; Mensa J; Vila J; Martínez JA .

  See complete list of authors

  Reference: PLOS ONE 2016.